Superpower operates a consumer-facing longevity platform that combines annual blood testing with personalized health analytics and clinical guidance. Members receive analysis of over 100 biomarkers across 21 categories, designed to detect early signs of disease and track biological age. The service is available at 2,000+ partner lab locations or through home visits, priced at $199 annually or $17 monthly.
The platform generates personalized health plans based on individual biomarker results and provides access to clinical guidance, prescriptions, and supplements. Members can monitor changes in their biological age over time and identify early risk factors for conditions including diabetes and cardiovascular disease. The company claims its testing is roughly ten times more comprehensive than a standard physical examination.
Superpower has raised $30 million in Series A funding from Forerunner Ventures and Susa Ventures, and operates with 51-200 employees. The service has attracted over 3,000 members. The company positions its offering as making detailed health intelligence accessible to consumers seeking to understand and manage their long-term health trajectories.
